Paula Ragan | executive |
Adam Mostafa | executive |
Kristen Kluska | analyst |
Mark Baldry | executive |
Edward Tenthoff | analyst |
Christophe Arbet-Engels | executive |
Xun Lee | analyst |
Stephen Willey | analyst |
Greetings, and welcome to the X4 Pharmaceuticals' Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Dan Ferry from LifeSci Advisors. Please begin.